Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

MADIT-CRT: Resynchronization linked to fewer heart failure hospitalizations

Publish date:: November 3, 2020

Key clinical point: Placement of a CRT-D device may reduce hospitalizations in selected heart failure patients with left bundle branch block.

Major finding: Hospitalization for heart failure occurred in 12% of patients treated with CRT-D and 22% of those who received an ICD.

Study details: Post hoc analysis of data collected in MADIT-CRT, a multicenter randomized study with 1,820 patients followed for an average of 5.6 years.

Disclosures: MADIT-CRT was funded by Boston Scientific, which markets several CRT-D devices. Dr. Thomas had no disclosures.

Citation:

Thomas S et al. HFSA 2020, Abstract 019.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Annual WCC visits significantly limit asthma worsening,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Microplastics permeate human placentas,

Must Reads in Cardiology

Sac/val heart failure benefit extends to diabetes patients,

Sedentary postmenopausal women have higher heart failure risk,

Experts disagree with USPSTF’s take on pediatric blood pressure screening,

GALACTIC-HF: New ‘myotropic’ drug class shows modest HFrEF benefit,

Don’t miss cardiovascular risk factors in transgender patients,